Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results

Author's Avatar
Aug 15, 2018
Article's Main Image

Signs Agreement to be Acquired by Catalent, Inc.

CRINONE® Revenues Increased 12% and Juniper Pharma Services (JPS) Revenues Increased 41% for the Six-months Ended June 30, 2018 vs. Prior Year

PR Newswire